Missense mutations (p.H371Y, p.D438Y) in gene CHEK2 are associated with breast cancer risk in women of Balochistan origin
- 517 Downloads
CHEK2 encodes a serine/threonine-protein kinase which plays a critical role in DNA damage signaling pathways. CHEK2 directly phosphorylates and regulates the functions of p53 and BRCA1. Most women with breast and/or ovarian cancer are not carriers of mutant BRCA1 or BRCA2. Multiple studies have shown that a CHEK2*1100delC confers about a two-fold increased risk of breast cancer in unselected females and a tenfold increase in males. Moreover, studies have shown that first-degree relatives of bilateral breast cancer cases who carried the CHEK2*1100delC allele had an eight-fold increased risk of breast cancer. It has been suggested that CHEK2 functions as a low-penetrance susceptibility gene for cancers and multiplies the risks associated with other gene(s) to increase cancer risk. The main goal of this study was to evaluate and to compare the role of truncating mutations, splice junction mutations and rare missense substitutions in breast cancer susceptibility gene CHEK2. Present study was performed on 140 individuals including 70 breast cancer patients both with and without family history and 70 normal individuals. Written consent was obtained and 3 ml intravenous blood was drawn from all the subjects. DNA was extracted from all the samples through inorganic method published already. Primers were synthesized for all the 14 exons of CHEK2 gene. Coding and adjacent intronic sequences of CHEK2 gene were amplified and sequenced. Two genetic variants (p.H371Y, p.D438Y) were found in exon 10 and exon 11 of gene CHEK2 which were not found in any of the 70 control individuals from same geographical area and ethnic group. The genetic variant c.1312G>T (p.D438Y) identified in a patient with a family history of breast cancer. To our knowledge, this is first mutation scanning study of gene CHEK2 from Balochistan population.
KeywordsCHEK2 Breast cancer Balochistan Intermediate breast cancer gene Mutational analysis
We thank all the participants who voluntarily took part in this study. This research work was supported by IARC through research grant (CRT No. Fel/11/01) to Jamil Ahmad and partial financial support was provided by ORIC, BUITEMS. We also thank director CENAR and his team for their kind support.
- 11.Novak DJ, Chen LQ, Ghadirian P, Hamel N, Zhang P, Rossiny V, Cardinal G, Robidoux A, Tonin PN, Rousseau F, Narod SA, Foulkes WD (2008) Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women. BMC Cancer 8:239CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu MC, Martin M, Namer M, O’Shaughnessy JA, Shen ZZ, Albain KS (2005) ABREAST investigators: the global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6:391–401CrossRefPubMedGoogle Scholar
- 13.Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, Yasmeen S, Anderson G (2009) Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 360:573–587CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Ahmad J, Le Calvez-Kelm F, Daud S, Voegele C, Vallée M, Ahmad A, Kakar N, McKay JD, Gaborieau V, Léoné M, Sinilnikova O, Sangrajrang S, Tavtigian SV, Lesueur F (2012) Detection of BRCA1/2 mutations in breast cancer patients from Thailand and Pakistan. Clin Genet 82:594–598CrossRefPubMedGoogle Scholar
- 17.Naeem M, Khan N, Aman Z, Nasir A, Samad A, Khattak A (2008) Breast cancer: experience at lady reading hospital, Peshawar. J Ayub Med Coll 20:22–25Google Scholar
- 18.Bhurgri Y, Kayani N, Faridi N, Pervez S, Usman A, Bhurgri H, Malik J, Bashir I, Bhurgri A, Hasan SH (2007) Patho-epidemiology of breast cancer in Karachi ‘1995–1997’. Asia Pac J Cancer Prev 8:215–220Google Scholar
- 22.Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton MR (2002) CHEK2-breast cancer consortium. Low penetrance susceptibility to breast cancer due toCHEK2 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55–59CrossRefPubMedGoogle Scholar
- 23.Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP, Nevanlinna H (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432–438CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Calvez-Kelm FL, Lesueur F, Damiola F, Vallee M, Voegele C, Babikyan D, Durand G, Forey N, McKay-Chopin S, Robinot N, Nguyen-Dumont T, Thomas A, Byrnes GB. (2011). Breast cancer family registry. Hopper J, Southey MC, Andruliss IL, John EM, Tavtigian SV (Ed.), Rare, evolutionarily unlikely missense substitutions in CHEK2 contributes to breast cancer susceptibility: results from a breast cancer family registry case–control mutation-screening study. Breast Cancer Res 13: R6Google Scholar
- 26.Fletcher O, Johnson N, Dos Santos SI, Kilpivaara O, Aittomaki K, Blomqvist C, Nevanlinna H, Wasielewski M, Meijers-Heijerboer H, Broeks A, Schmidt MK, Van’t Veer LJ, Bremer M, Dork T, Chekmariova EV, Sokolenko AP, Imyanitov EN, Hamann U, Rashid MU, Brauch H, Justenhoven C, Ashworth A, Peto J (2009) Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls. Cancer Epidemiol Biomarkers Prev 18:230–234CrossRefPubMedPubMedCentralGoogle Scholar
- 28.McKay-Chopin, for Kathrine Cuningham Foundation Consortium for research into Familial Aspects of Breast Cancer (kConFab), Nguyen-Dumont T, Jordheim LP, Michelon J, Forey N, Sinilnikova O, Calvez-kelm FL, Southey MC, Tavtigian SV, Lesueur F (2011) Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2. BMC Med Genomics 4:39CrossRefGoogle Scholar